POLYFLEX DIN 00857629
Status: Cancelled Post Market
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Molecule: AMPICILLIN (AMPICILLIN TRIHYDRATE)
Health Canada record
| Active ingredient(s) | AMPICILLIN (AMPICILLIN TRIHYDRATE) 10 G |
|---|---|
| Dosage form | Powder For Suspension |
| Route | Subcutaneous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1990 |
| Current status date | 19-Jul-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMPICILLIN (AMPICILLIN TRIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00849405 | POLYFLEX | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Powder For Suspension | AMPICILLIN (AMPICILLIN TRIHYDRATE) 25 G | Marketed |
| 00020877 | TEVA-AMPICILLIN | TEVA CANADA LIMITED | Capsule | AMPICILLIN (AMPICILLIN TRIHYDRATE) 250 MG | Marketed |
| 00020885 | TEVA-AMPICILLIN | TEVA CANADA LIMITED | Capsule | AMPICILLIN (AMPICILLIN TRIHYDRATE) 500 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22242 | 2019-06-06 | Supplement to a New Drug Submission (SNDS) | MANUFACTURING CHANGE |
| 11789 | 2010-10-06 | New Drug Submission (NDS) | Change in ownership |
| 3630 | 2004-05-19 | New Drug Submission (NDS) | |
| 6108 | 2002-05-02 | Supplement to a New Drug Submission (SNDS) | ALTERNATE SOURCE OF ACTIVE INGREDIENT |
| 6886 | 1998-06-01 | New Drug Submission (NDS) |